Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24688 | 254 | 28.9 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARANE DERIVATIVES | Author keyword | 4 | 67% | 2% | 4 |
2 | AII RECEPTORS | Author keyword | 1 | 50% | 0% | 1 |
3 | BLOOD PLATELET | Author keyword | 1 | 50% | 0% | 1 |
4 | ISRAPIDINE | Author keyword | 1 | 50% | 0% | 1 |
5 | PERINDOPRIL THERAPY | Author keyword | 1 | 50% | 0% | 1 |
6 | PLATELET AGGREGATION INHIBITION | Author keyword | 1 | 50% | 0% | 1 |
7 | PLATELET ANGIOTENSIN II RECEPTORS | Author keyword | 1 | 50% | 0% | 1 |
8 | HEMOSTATIC FACTOR | Author keyword | 0 | 25% | 0% | 1 |
9 | HLTH SCI CLIN PHARMACOL | Address | 0 | 25% | 0% | 1 |
10 | PAVILLON ST FRANCOIS ASSISE | Address | 0 | 25% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLATELET ALPHA2 ADRENOCEPTOR ALTERATIONS | 1 | 50% | 0% | 1 |
2 | OUTCOMES TRIAL ASCOT | 1 | 22% | 1% | 2 |
3 | CATECHOLAMINE MEASUREMENTS | 0 | 33% | 0% | 1 |
4 | SERINE BASE EXCHANGE | 0 | 33% | 0% | 1 |
5 | PLASMA BETA THROMBOGLOBULIN | 0 | 15% | 1% | 2 |
6 | BLOOD FLOW CYTOMETRY | 0 | 20% | 0% | 1 |
7 | PIG PLATELETS | 0 | 20% | 0% | 1 |
8 | PLASMA CYCLIC AMP | 0 | 20% | 0% | 1 |
9 | RENAL ARTERIAL DISEASE | 0 | 20% | 0% | 1 |
10 | INTRACELLULAR MESSENGER | 0 | 10% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacological modulation of platelet function in hypertension | 2003 | 42 | 90 | 23% |
ACTIVATION OF XENOBIOTICS INTO FREE-RADICALS BY PROSTAGLANDIN-H-SYNTHASE AND BY RAT-LIVER MICROSOMES | 1995 | 0 | 1 | 100% |
Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine | 1997 | 126 | 77 | 10% |
DEFINITION OF PLATELET-DERIVED HISTAMINE RELEASING-FACTOR (PDHRF) AND HISTAMINERGIC RECEPTORS MODULATING PLATELET-AGGREGATION | 1991 | 0 | 4 | 75% |
The prothrombotic state in hypertension and the effects of antihypertensive treatment | 2003 | 39 | 176 | 11% |
Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors | 2006 | 19 | 108 | 9% |
Platelet function and fibrinolytic activity in borderline and mild hypertension - The influence of age, exercise, smoking and antihypertensive therapy | 2002 | 1 | 134 | 16% |
PLATELET BETA-ADRENOCEPTOR FUNCTION - EXPERIMENTAL AND CLINICAL-STUDIES WITH SPECIAL REFERENCE TO AGE AND STRESS | 1991 | 3 | 69 | 28% |
THE HYPERTENSION CORONARY HEART-DISEASE DILEMMA - THE CATECHOLAMINE BLOOD-PLATELET CONNECTION | 1989 | 21 | 84 | 8% |
Pharmacological role of the atenolol/nifedipine combination in hypertensive patients | 1998 | 3 | 12 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HLTH SCI CLIN PHARMACOL | 0 | 25% | 0.4% | 1 |
2 | PAVILLON ST FRANCOIS ASSISE | 0 | 25% | 0.4% | 1 |
3 | PROP MED 2 | 0 | 25% | 0.4% | 1 |
4 | REG PHYSICOCHEM ANAL | 0 | 25% | 0.4% | 1 |
5 | CARDIOL COMPLEX | 0 | 20% | 0.4% | 1 |
6 | IRCCS INTERNAL MED THER EUT | 0 | 17% | 0.4% | 1 |
7 | UNIDAD CARDIOCIRCULAC | 0 | 17% | 0.4% | 1 |
8 | REG PHYSIOCHEM ANAL STRUCT | 0 | 13% | 0.4% | 1 |
9 | UNIDAD BIOL PATOL CELULAR | 0 | 11% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000174198 | PLATELET PMN INTERACTION//ATHLETIC HORSE//B TG |
2 | 0.0000153664 | PLASMA RECALCIFICATION//TAIL BLEEDING TIME//RAT PLATELET |
3 | 0.0000147445 | HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2 |
4 | 0.0000145187 | COAGULATION ABNORMALITY//D L LYSINACETYLSALICYLATE//SECT CLIN GERONTOL VASC MED |
5 | 0.0000124026 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY//PREECLAMPSIA PREVENTION//LOW DOSE ASPIRIN |
6 | 0.0000117008 | ABT MED FOR//CARDIOSELECTIVE BETA RECEPTOR ANTAGONIST//PAREXEL GMBH |
7 | 0.0000090950 | PATOL VASC NEFROL EXPT//VASC RENAL PATHOL//MED ALFREDO LANARI |
8 | 0.0000086783 | MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES |
9 | 0.0000083508 | ENDOTHELAEMIA//INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR//ENDOTHELEMIA |
10 | 0.0000083458 | NONMODULATION//HYPERTENSION NONMODULATING//EXTREME NORTH |